MS Pharmacology


MS Pharmacology

Main Content

The MS Pharmacology program has a translational pharmacology focus - bridging across the discovery, development, regulation, and use of pharmacologic agents to improve clinical outcomes and inform optimal use of therapeutics in patients.

This program is designed for recent graduates and professionals interested in a career in clinical and translational pharmacology, specializing in clinical trial design or preclinical toxicology and safety pharmacology studies.

The degree is appropriate for physicians, pharmacists, nurse practitioners, nurses, and other healthcare practitioners, as well as those having completed a BS or graduate degree in the pharmaceutical sciences or another bioscience-related field. The program offers two tracks to specialize your training:

Clinical Pharmacology Specialization

The Clinical Pharmacology Specialization focuses on the application of pharmacological principles in clinical research, connecting the gap between laboratory science and clinical practice. Research team members assist clinical pharmacologists to study biomarkers, pharmacokinetics, and genetics; design and evaluate clinical trials; and investigate adverse reactions and drug interactions in patients in drug studies.

Toxicology and Safety Pharmacology Specialization

In the Toxicology and Safety Pharmacology Specialization, students learn to improve the discovery, development, and safe use of biologically active substances by identifying, monitoring, and characterizing potential undesirable effects in preclinical studies. Toxicologists and safety pharmacologists plan, conduct, and report the results of in vivo and in vitro tests of drugs on cardiovascular function, respiratory function, and central nervous system behavior prior to the introduction in humans.

The MS Pharmacology curriculum consists of a minimum of 30 credits organized into three curricular domains:

  1. Clinical and translational pharmacology and toxicology coursework (9-15 credits)
  2. Conduct of clinical trials or preclinical studies coursework, including courses in biostatistics (6-18 credits)
  3. Culminating master’s activity (three credits min.), a clinical/preclinical research practicum or project